Boston Scientific stock forecast
Boston Scientific (BSX) Stock Forecast & Price Target
BSX Analyst Ratings
BSX Stock 12 Month Forecast
Average Price Target
CHF40.76▲(0.00% Upside)Detailed List of Analyst Forecasts​
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Joanne Wuensch | Citi | CHF39.08→CHF35.83 | hold | ― | Assigned | 11/03/26 | ||
| William Plovanic | Canaccord Genuity | CHF39.08 | buy | ― | Reiterated | 11/03/26 | ||
| Robbie Marcus | J.P. Morgan | ― | hold | ― | Reiterated | 11/02/26 | ||
| David Toung | Argus Research | ― | hold | ― | Reiterated | 11/02/26 | ||
| Christopher Pasquale | Barclays | CHF39.08→CHF36.64 | hold | ― | Reiterated | 10/30/26 | ||
| Josh Jennings | TD Cowen | CHF45.60→CHF37.46 | hold | ― | Downgraded | 10/30/26 | ||
| Travis Steed | Bank of America Securities | CHF43.97 | buy | ― | Reiterated | 10/30/26 | ||
| Mike Kratky | Leerink Partners | CHF44.78→CHF40.71 | buy | ― | Reiterated | 10/29/26 | ||
| David Rescott | Robert W. Baird | CHF40.71→CHF41.53 | buy | ― | Reiterated | 10/29/26 | ||
| Suraj Kalia | Oppenheimer | ― | hold | ― | Downgraded | 10/29/26 | ||
| Anthony Petrone | Mizuho Securities | CHF44.78→CHF40.71 | buy | ― | Reiterated | 10/29/26 | ||
| Lee Hambright | Bernstein | CHF43.97→CHF39.90 | buy | ― | Reiterated | 10/29/26 | ||
| Patrick Wood | UBS | CHF54.56→CHF46.41 | buy | ― | Assigned | 10/29/26 | ||
| Pito Chickering | Deutsche Bank | CHF48.86→CHF39.08 | buy | ― | Reiterated | 10/29/26 | ||
| Michael Matson | Needham | CHF46.41→CHF39.08 | buy | ― | Reiterated | 10/28/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Joanne WuenschCiti | HoldAssignedCHF39.08→CHF35.83 | 11/03/26 | ― | ||
| William PlovanicCanaccord Genuity | BuyReiteratedCHF39.08 | 11/03/26 | ― | ||
| Robbie MarcusJ.P. Morgan | HoldReiterated | 11/02/26 | ― | ||
| David ToungArgus Research | HoldReiterated | 11/02/26 | ― | ||
| Christopher PasqualeBarclays | HoldReiteratedCHF39.08→CHF36.64 | 10/30/26 | ― | ||
| Josh JenningsTD Cowen | HoldDowngradedCHF45.60→CHF37.46 | 10/30/26 | ― | ||
| Travis SteedBank of America Securities | BuyReiteratedCHF43.97 | 10/30/26 | ― | ||
| Mike KratkyLeerink Partners | BuyReiteratedCHF44.78→CHF40.71 | 10/29/26 | ― | ||
| David RescottRobert W. Baird | BuyReiteratedCHF40.71→CHF41.53 | 10/29/26 | ― | ||
| Suraj KaliaOppenheimer | HoldDowngraded | 10/29/26 | ― | ||
| Anthony PetroneMizuho Securities | BuyReiteratedCHF44.78→CHF40.71 | 10/29/26 | ― | ||
| Lee HambrightBernstein | BuyReiteratedCHF43.97→CHF39.90 | 10/29/26 | ― | ||
| Patrick WoodUBS | BuyAssignedCHF54.56→CHF46.41 | 10/29/26 | ― | ||
| Pito ChickeringDeutsche Bank | BuyReiteratedCHF48.86→CHF39.08 | 10/29/26 | ― | ||
| Michael MatsonNeedham | BuyReiteratedCHF46.41→CHF39.08 | 10/28/26 | ― |
Best Analysts Covering Boston Scientific
Copying Matthew O'Brien's trades and holding each position for 3 Months would result in 64.52% of your transactions generating a profit, with an average return of +3.50% per trade.
Copying Jayson Bedford's trades and holding each position for 1 Year would result in 73.58% of your transactions generating a profit, with an average return of +12.13% per trade.
Copying Jayson Bedford's trades and holding each position for 2 Years would result in 77.36% of your transactions generating a profit, with an average return of +22.84% per trade.
BSX Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 18 | 8 | 7 | 1 | 1 |
| Buy | 47 | 41 | 39 | 37 | 31 |
| Hold | 4 | 2 | 4 | 10 | 13 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 69 | 51 | 50 | 48 | 45 |
In the current month, BSX has received 32 Buy Ratings, 13 Hold Ratings, and 0 Sell Ratings. BSX average Analyst price target in the past 3 months is 40.76.
BSX Financial Forecast
BSX Earnings Forecast
Next quarter’s earnings estimate for BSX is CHF 0.64 with a range of CHF 0.63 to CHF 0.65. The previous quarter’s EPS was CHF 0.60. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.
BSX Sales Forecast
Next quarter’s sales forecast for BSX is CHF 4.28B with a range of CHF 4.24B to CHF 4.33B. The previous quarter’s sales results were CHF 4.24B. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.

